<DOC>
	<DOCNO>NCT01872780</DOCNO>
	<brief_summary>The genotype profile CYP2C8 analyze Korean population . Frequency multi-ethnic population vivo functionality novel null allelic CYP2C8 variant evaluate .</brief_summary>
	<brief_title>Identification Null Allelic Variant CYP2C8 In A Korean Population</brief_title>
	<detailed_description>Whole blood sample 50 unrelated Korean subject genotyped 3kb 5 ' upstream region , exon-intron boundary , exon , UTR region CYP2C8 gene direct sequencing . Genotyping CYP2C8 address null allelic variant , CYP2C8*11 use pyrosequencing 447 Koreans , 93 African-Americans , 100 Caucasians , 348 Chineses 100 Vietnameses . Then , in-vivo single PK study CYP2C8 probe , rosiglitazone ( 4mg ) , conduct 7 healthy subject CYP2C8*1/*1 2 CY2C8*1/*11 .</detailed_description>
	<mesh_term>Rosiglitazone</mesh_term>
	<criteria>Healthy volunteer Medical problem take probe drug</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>CYP2C8</keyword>
	<keyword>genetic polymorphism</keyword>
	<keyword>rosiglitazone</keyword>
	<keyword>Korean</keyword>
</DOC>